Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Direct connect single layer touch panel
Wristband with detachable labels
Device chip carriers, modules, and methods of forming thereof
Utility knife
Fabric care compositions comprising front-end stability agents
Rechargeable battery
  Randomly Featured Patents
Optically active cyclic alcohol compound and method for preparing the same
Condiment grinder
Method and apparatus for preventing un-authorized attachment of computer peripherals
Process for continuously electroforming parts such as inkjet orifice plates for inkjet printers
Multihull vessels
Condensation process
Optical disc apparatus and method for recording data onto an optical disc in multiple write sessions
Process for forming a fire retardant intumescent material having two stages of expansion
Video storage unit architecture